Antioxidant effect of zinc in humans

Free Radical Biology and Medicine

Volumn 37, Issue 8, 2004, Pages 1182-1190

  Prasad, Ananda S ^a,b   Bao, Bin ^a   Beck, Frances W J ^a   Kucuk, Omer ^a   Sarkar, Fazlul H ^b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant; DNA oxidation; Free radicals; IL 1 ; NF B; TNF ; Zinc

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; DNA; GLUCONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; ISOPROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PLACEBO; TRANSFORMING GROWTH FACTOR ALPHA; ZINC;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; CELL ISOLATION; CELL STRAIN HL 60; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROMYELOCYTE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; UPREGULATION; VOLUNTEER;

EID: 4644308853     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.07.007     Document Type: Article

References (45)

1. A.S. Prasad, J.A. Halsted, and M. Nadimi Syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism and geophagia Am. J. Med. 31 1961 532 546
2. A.S. Prasad, A. Miale, Z. Farid, H.H. Sandstead, and A.R. Schulert Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, and dwarfism J. Lab. Clin. Med. 61 1963 537 549
3. A.S. Prasad Zinc in human health: an update J. Trace Elem. Exp. Med. 11 1998 63 87
4. A.S. Prasad Biochemistry of zinc 1993 Plenum New York
5. L. Castro, and B.A. Freeman Reactive oxygen species in human health and disease Nutrition 17 2001 161 165
6. J.N. Davis, O. Kucuk, Z. Djuric, and F.H. Sarkar Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes Free Radic. Biol. Med. 30 2001 1293 1302
7. P.A. Lachance, Z. Nakat, and W. Jeong Antioxidants: an integrative approach Nutrition 17 2001 835 838
8. Y. Ozaki, T. Ohashi, and S. Kume Potentiation of neutrophil function by recombinant DNA-produced interleukin-1α J. Leukocyte Biol. 42 1987 621 627
9. R.L. Berkow, D. Wang, J.W. Larrick, R.W. Dodson, and T.H. Howard Enhancement of neutrophil superoxide production by pre-incubation with recombinant human tumor necrosis factor J. Immunol. 139 1987 3783 3791
10. A. Kocyigit, S. Gur, O. Erel, and M.S. Gurel Associations among plasma selenium, zinc, copper, and iron concentrations and immunoregulatory cytokine levels in patients with cutaneous leishmaniasis Biol. Trace Elem. Res. 90 2002 47 55
11. M. Demirci, N. Delibas, I. Altuntas, F. Oktem, and Z. Yonden Serum iron, zinc and copper levels and lipid peroxidation in children with chronic giardiasis J. Health Popul. Nutr. 21 2003 72 75
12. A.S. Prasad, B. Bao, F.W.J. Beck, and F.H. Sarkar Zinc activates NF-κB in HUT-78 cells J. Lab. Clin. Med. 138 2001 250 256
13. A.S. Prasad, B. Bao, F.W.J. Beck, and F.H. Sarkar Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-κB activation J. Lab. Clin. Med. 140 2002 272 289
14. R.G. Uzzo, P. Leavis, W. Hatch, V.L. Cabai, N. Dulin, N. Zvartau, and V.M. Kolenko Zinc inhibits nuclear factor-κB activation and sensitizes prostate cancer cells to cytotoxic agents Clin. Cancer Res. 8 2002 3579 3583
15. C.H. Kim, J.H. Kim, S.J. Moon, K.C. Chung, C.Y. Hsu, J.T. Seo, and Y.S. Ahn Pyrithione, a zinc ionophore, inhibits NF-kappaB activation Biochem. Biophys. Res. Commun. 259 1999 505 509
16. E. Ho, N. Quan, Y.H. Tsai, W. Lai, and T.M. Bray Dietary zinc supplementation inhibits NF-kappa B activation and protects against chemically induced diabetes in CD1 mice Exp. Biol. Med. 226 2001 103 111
17. K. Otsu, Y. Ikeda, and J. Fujii Accumulation of manganese superoxide dismutase under metal-depleted conditions: proposed role for zinc ions in cellular redox balance Biochem. J. 377 2004 241 248
18. A.W. Opipari Jr., M.S. Boguski, and V.M. Dixit The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein J. Biol. Chem. 265 1990 14705 14708
19. A. Krikos, C.D. Laherty, and V.M. Dixit Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by κB elements J. Biol. Chem. 267 1992 17971 17976
20. K. Heyninck, and R. Beyaert The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6 FEBS Lett. 442 1999 147 150
21. M. Jaattela, H. Mouritzen, F. Elling, and L. Bastholm A20 zinc finger protein inhibits TNF and IL-1 signaling J. Immun. 156 1996 1166 1173
22. H.Y. Song, M. Rothe, and D.V. Goeddel The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation Proc. Natl. Acad. Sci. USA 93 1996 6721 6725
23. H. Wang, A.S. Prasad, and E. DuMouchelle Zinc in platelets, lymphocytes and granulocytes by flameless atomic absorption spectrophotometry (AAS) J. Micro Nutr. Anal. 5 1989 181 190
24. C. Yamasaki, Y. Natotri, X.T. Zeng, M. Ohmura, S. Yamasaki, Y. Takeda, and Y. Natotri Induction of cytokines in human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non-toxic mutant Stx1 which lacks N-glycosidase activity FEBS Lett. 442 1999 231 234
25. M.B. Miranda, K.F. Dyer, J.R. Grandis, and D.E. Johnson Differential activation of apoptosis regulatory pathways during monocytic vs granulocytic differentiation: a requirement for Bcl-X(L) and XIAP in the prolonged survival of monocytic cells Leukemia 17 2003 390 400
26. A. Deptala, E. Bedner, W. Gorczyca, and Z. Darzynkiewicz Activation of nuclear factor kappa B (NF-kappa B) assayed by laser scanning cytometry (LSC) Cytometry 33 1998 376 382
27. A.H. Liu, F. Liu, Z. Li, J.X. Gu, and H.L. Chen Alterations in glycosyltransferases during myeloid and monocytic differentiation of HL-60 cells Cell Biol. Int. 22 1998 545 550
28. B. Bao, A.S. Prasad, F.W. Beck, and M. Godmere Zinc modulates mRNA levels of cytokines Am. J. Physiol. Endocrinol. Metab. 285 2003 E1095 E1102
29. W.J. Bettger Zinc and selenium, site-specific versus general antioxidant Can. J. Physiol. Pharmacol. 71 1993 721 724
30. M.I. Yousef, H.A. El-Hendy, F.M. El-Demerdash, and E.I. Elagamy Dietary zinc deficiency-induced changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats Toxicology 175 2002 223 234
31. E. Ho, C. Courtemanche, and B.N. Ames Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts J. Nutr. 133 2003 2543 2548
32. E. Ho, and B.N. Ames Low intracellular zinc induces oxidative DNA damage, disrupts NF-kappa B, and AP1 DNA binding, and affects DNA repair in a glioma cell line Proc. Natl. Acad. Sci. USA 99 2002 16770 16775
33. B. Hennig, P. Meerarani, M. Toborek, and C.J. McClain Antioxidant-like properties of zinc in activated endothelial cells J. Am. Coll. Nutr. 18 1999 152 158
34. A.M. Roussel, A. Kerkeni, N. Zouari, S. Mahjoub, J.M. Matheau, and R.A. Anderson Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus J. Am. Coll. Nutr. 22 2003 316 321
35. F. Candan, F. Gultekin, and F. Dandau Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc deficient hemodialysis patients Cell Biochem. Funct. 20 2002 95 98
36. Age-Related Eye Disease Study Research Group A randomized, placebo controlled, clinical trial of high-dose supplemented with vitamins C and E, beta-carotene, for age-related macular degeneration and vision loss (AREDS Report No. 8) Arch. Ophthalmol. 119 2001 1417 1436
37. P. Connell, V.M. Young, M. Toborek, D.A. Cohen, S. Barve, C.J. McClain, and B. Hennig Zinc attenuates tumor necrosis factor mediated activation of transcription factors in endothelial cells J. Am. Coll. Nutr. 16 1997 411 417
38. M. Tewari, F.W. Wolf, M.F. Seldin, K.S. O'Shea, V.M. Dixit, and L.A. Turka Lymphoid expression and regulation of A20, an inhibitor of programmed cell death Immunology 154 1995 1699 1706
39. B. Beutler TNF, immunity and inflammatory disease: lessons of the past decade J. Invest. Med. 43 1995 227 235
40. J.E. Pennington Therapy with antibody to tumor necrosis factor in sepsis Clin. Infect. Dis. 17 1993 S5515 S5519
41. M.J. Elliott, R.N. Maini, M. Feldmann, J.R. Kalden, C. Antoni, J.S. Smolen, B. Leeb, F.C. Breedveld, and J.D. Macfarlane Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (CA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110
42. S.M. Opal, and V.A. DePalo Impact of basic research on tomorrow's medicine: anti-inflammatory cytokines Chest 117 2002 1162 1172
43. A.S. Prasad, G.J. Brewer, E.B. Schoomaker, and P. Rabbani Hypocupremia induced by zinc therapy in adults JAMA 240 1978 2166 2168
44. C.T. Walsh, H.H. Sandstead, A.S. Prasad, P.M. Newberne, and P.J. Fraker Zinc: health effects and research priorities for the 1990's Environ. Health Perspect. 102 Suppl. 2 1994 5 46
45. R. Beyaert, K. Heyninck, and S. Van Huffel A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis Biochem. Pharmacol. 60 2000 1143 1151